9th Global Summit on Microbiology & Infectious Diseases
Euro Clinical Microbiology 2019 is glad to announce the upcoming “9th Global Summit on Microbiology and Infectious Diseases” to be held on March 04-06, 2019 at Prague, Czech Republic.
Euro Clinical Microbiology 2019 takes immense pleasure in inviting the scientists, researchers, professors, delegates across the continents to the upcoming clinical microbiology conference based on theme "Advanced Research and application of new methods in Clinical Microbiology”.
Euro Clinical Microbiology 2019 organizes about over 1000 Global Events which are inclusive of the 400+ Conferences, 300+ Workshops and about 300+ Symposiums every year throughout the world- across USA, Europe & Asia-Pacific with the support of over 1000 scientific societies, while having already published about more than 500 Open access journals containing over 50,000 eminent and reputed scientists as editorial board members.
Student Poster Competition is organized at Conference, to encourage students and recent graduates to present their original research which will be later published in our supporting International Journals. All accepted abstracts will be presented at the poster sessions during the conference. Conference Series provides an opportunity to present E-Poster for all the students who cannot attend the conference. Abstract published in the website with DOI number Live Streaming is a value added service offering to speaker at Euro Clinical Microbiology 2019.
Business networking is an avenue for vendors to have network and B2B meetings with “Top scientists and colleagues” and with an effective low cost marketing method for developing sales and opportunities and contacts, based on referrals and introductions either face-to-face at meetings and gatherings, or by other contact methods such as Telephone, E mail, Digital and Increasingly social and business networking websites.
For Researchers and Faculty Members:
Symposium hosting (4-5 member team)
For Universities, Associations & Societies:
For Students and Research Scholars:
Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
For Business Delegates:
Book Launch event
For Product Manufacturers:
Exhibitor and Vendor booths
Marketing and Networking with clients
Microbiology Conferences organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Euro Clinical Microbiology 2019 ardently encourages patrons, benefactors, pioneers, and exhibitors from across the world to convene you all to attend and register for the 9th Global Summit on Microbiology and Infectious Diseases” which is going to be held on March 04-06, 2019 at Prague, Czech Republic.
Microbiology Conference have been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industries belonging to Microbial, Biotech and Pharmaceuticals sectors and academia.
The organizing committee is endowing for a rather stimulating and illuminative conference programs subsuming Plenary Lectures, Symposia, Workshops on a myriad of topics, Poster Presentations and an assortment of programs for participants from over the globe. We invite you to accompany us at the Euro Clinical Microbiology 2019, where you are assured to have a substantially worthwhile experience with ecumenical scholars. All the representatives of Euro Clinical Microbiology 2019 organizing committee look forward to meet you at Prague, Czech Republic.
Track 1: Microbiology Research and Advancements
Rapid identification of microorganisms in the clinical microbiology can be of great value for selection of optimal patient management strategies for infections caused by bacteria, viruses, fungi, mycobacteria, and parasites. Rapid identification of microorganisms in clinical samples enables expedient de-escalation from broad-spectrum agents to targeted antimicrobial therapy. The switch to tailored therapy minimizes risks of antibiotics, namely, disruption of normal flora, toxic side effects, and selective pressure. There is a critical need for new technologies in clinical microbiology, particularly for bloodstream infections, in which associated mortality is among the highest of all infections. Just as importantly, there is a need for the clinical laboratory community to embrace the practices of evidence-based interventional laboratory medicine and collaborate in translational research projects to establish the clinical utility, cost benefit, and impact of new technologies.
Track 2: Microbes in Human Welfare
Microbes are a very important component of life on earth. Not all microbes are pathogenic. Many microbes are very useful to human beings. We use microbes and microbially derived products almost every day. Antibiotics have played a major role in controlling infectious diseases like diphtheria, whooping cough and pneumonia. Microbes brings lot of welfare for human beings in Vaccination and Antibiotics, Household Products like Lactobacillus is a bacterium that is found in curd, Sewage Treatment -Bacteria such as Nitrosomonas, Nitrobacter, are involved in fermenting sewage. Pseudomonas is also one of the bacteria involved in breakdown of organic matter. Gobar Gas Formation- Gobar gas is formed anaerobically by Methanobacterium. Viruses are used as a vector for transmission of required gene during recombinant DNA Technology.
Track 3: Microbial Vaccines
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and remember it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Track 4: Infection Prevention and Control
Infection prevention and control is required to prevent the transmission of communicable diseases in all health care settings. Infection prevention and control demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. The risk of acquiring a health care-associated infection is related to the mode of transmission of the infectious agent, the type of patient-care activity or procedure being performed and the underlying patient’s host defenses. Vaccination is the best way to protect yourself and others from various infectious diseases.
Track 5: Infection and Immunity
Immunology is the branch of science concerned with the various aspects related to immune system, innate and acquired immunity and immunology also deals with laboratory techniques involving the interaction of antigens with specific antibodies. Microbiology is the branch of science dealing with the study of various microorganisms. Microbiology involves the study of their structure and various physical, chemical and biological characteristics pertaining to their capability to cause a disease. Medical diagnosis is the process of determining which disease or condition explains a person's symptoms and signs. Laboratory tests may identify organisms directly (e.g., visually, using a microscope, growing the organism in culture) or indirectly (e.g., identifying antibodies to the organism). General types of tests include Microscopy, Culture, Immunologic tests (agglutination tests such as latex agglutination, enzyme immunoassays, Western blot, precipitation tests, and complement fixation tests) and Nucleic acid/ Non-nucleic acid –based identification methods. Sub-types of diagnoses include: Clinical, Laboratory, Radiology, Principal and admitting diagnosis. Advanced methods have been implemented to diagnose the infection in any part of the body. Examples include Biomarkers/ ELISA test/ Chest X ray/ Skin biopsy/ Tympanometry and Tympanocentesis.
Track 6: Pathogenicity of Microbes
Pathogenicity refers to the ability of an organism to cause disease (ie, harm the host). This ability represents a genetic component of the pathogen and the overt damage done to the host is a property of the host-pathogen interactions. Commensals and opportunistic pathogens lack this inherent ability to cause disease. However, disease is not an inevitable outcome of the host-pathogen interaction and, furthermore, pathogens can express a wide range of virulence. Virulence, a term often used interchangeably with pathogenicity, refers to the degree of pathology caused by the organism. The extent of the virulence is usually correlated with the ability of the pathogen to multiply within the host and may be affected by other factors. The development of a disease state is a dynamic process that is dependent on the virulence of the pathogen and the resistance of the host. It covers biology, host-pathogen interaction and medicine associated with infectious agents, as well as microorganism, fungi, viruses and protozoa. Microbic pathological process is committed to the study of the genomic, molecular and cellular bases of clinical infectious diseases.
Track 7: Agricultural Microbiology
Agricultural microbiology is a field of study concerned with plant-associated microbes. It aims to address problems in agricultural practices usually caused by a lack of biodiversity in microbial communities. An understanding of microbial strains relevant to agricultural applications is useful in the enhancement of factors such as soil nutrients, plant-pathogen resistance, crop robustness, fertilization uptake efficiency and more. The many symbiotic relationships between plants and microbes can ultimately be exploited for greater food production necessary to feed the expanding human populace, in addition to safer farming techniques for the sake of minimizing ecological disruption.
Track 8: Antimicrobial Agents and Infectious diseases
Antimicrobials are agents killing or inhibiting the growth of microorganisms and are grouped as antibacterial, antivirals, antifungals and antiparasitics. Antibacterial used to treat bacterial infections are termed as antibacterial, treating virus are termed as antivirals and hence antifungals and antiparasitics are respectively for fungi and parasites. The toxicity of antibacterial to humans and other animals is generally low. Antimicrobial pesticides control growth of microbes by the use of disinfection, sanitation, or reduction of development and to protect industrial processes or systems, surfaces, water, or other chemical substances from contamination, spoiling caused by bacteria, viruses, fungi, protozoa, algae.
Track 9: Pharmaceutical Microbiology
Pharmaceutical Microbiology deals with the study of microorganisms that is concerned within the manufacture of prescribed drugs. Alternative aspects of pharmaceutical biological science embrace the analysis and development of anti-infective agents, the employment of microorganisms to sight agent and malignant neoplastic disease activity in prospective Medic*tion, and therefore the use of microorganisms within the manufacture of pharmaceutical product like endocrine and human growth hormone.
Track 10: Public Health Microbiology and Emerging Infectious Diseases
The Public Health and Microbiology concentration includes studies in microbial pathogenesis, principles of public health, epidemiology, molecular genetics, virology, and environmental and industrial microbial processes. This concentration prepares students for technical work or graduate school in microbial disease systems using polymerase chain reaction, other molecular diagnostic tools as well as environmental and industrial applications of microbial systems.
Track 11: Medical Microbiology
Medical microbiology is a branch of medicine dealing with the prevention, diagnosis and treatment of infectious as well as non-infectious diseases. Medical microbiologists deal with clinical consultations on the investigation, principles of diagnosis, treatment, and prevention of infectious diseases; the scientific development, administrative and medical direction of a clinical microbiology laboratory; the establishment and direction of infection control programs across the continuum of care; communicable disease prevention and epidemiology and related public health issues.
Track 12: Microbial Enzymes
Enzymes are considered as a potential biocatalyst for a large number of reactions. Particularly, the microbial enzymes have widespread uses in industries and medicine. The microbial enzymes are also more active and stable than plant and animal enzymes. In addition, the microorganisms represent an alternative source of enzymes because they can be cultured in large quantities in a short time by fermentation and owing to their biochemical diversity and susceptibility to gene manipulation. Industries are looking for new microbial strains in order to produce different enzymes to fulfill the current enzyme requirements.
Track 13: Microbial Biofilms
Aggregate of microorganisms in which cells that are frequently embedded within a self-produced matrix of extracellular polymeric substance (EPS) adhere to each other and/or to a surface. A biofilm is a system that can be adapted internally to environmental conditions by its inhabitants. The self-produced matrix of extracellular polymeric substance, which is also referred to as slime, is a polymeric conglomeration generally composed of extracellular biopolymers in various structural forms.
Track 14: Marine Microbiology
Marine microbiology is the study of the microorganisms (bacteria, archaea, viruses and microbial eukaryotes) in the marine environment, including their biodiversity, ecology and biogeochemistry. The use of met genomics has been fundamental in revealing the abundance and composition of marine microbial ecosystems.
Track 15: Microbes and Biofuels
Biofuel is energy source made of living things, or the waste that living things turn out. Supporters of biofuels argue that their use might considerably cut back greenhouse emissions; whereas burning the fuels produces CO2, growing the plants or biomass removes carbon diozide from the atmosphere. A biofuel could be a fuel that's created through up to date biological processes, like agriculture and anaerobic digestion, instead of a fuel created by geologic processes like those concerned within the formation of fossil fuels, like coal and crude oil, from prehistoric biological matter.
Track 16: Molecular Microbiology
Molecular microbiology is the branch of microbiology devoted to the study of the molecular basis of the physiological processes that occur in microorganisms. It deals with molecular mechanisms and physiological processes of microbes and their utilization in production of biotechnology products and medicines such as vaccines, antibodies. It also involves advancement in pathogenicity of microbes.
Please contact the event manager Marilyn (bWFyaWx5biAhIGIgISB0dXJuZXIgfCBueWV2ZW50c2xpc3QgISBjb20= ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorships
NO REFUNDS ALLOWED ON REGISTRATIONS
Service fees included in this listing.
This event is brought to you by:
Conference Series - NewYorkEventsList